Publications found:
36,694
Sort by:
Schistosomiasis R&D Pipeline Analysis Report, Q4 2020
US$ 1,529.00
Schistosomiasis Pipeline Overview The Q4 Schistosomiasis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under develop...
October 2020
48 pages
Sjogren Syndrome R&D Pipeline Analysis Report, Q4 2020
US$ 1,529.00
Sjogren Syndrome Pipeline Overview The Q4 Sjogren Syndrome pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs under developme...
October 2020
147 pages
Smallpox R&D Pipeline Analysis Report, Q4 2020
US$ 1,529.00
Smallpox Pipeline Overview The Q4 Smallpox pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Small...
October 2020
64 pages
Tetanus R&D Pipeline Analysis Report, Q4 2020
US$ 1,529.00
Tetanus Pipeline Overview The Q4 Tetanus pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Tetanus...
October 2020
132 pages
Toxoplasmosis R&D Pipeline Analysis Report, Q4 2020
US$ 1,529.00
Toxoplasmosis Pipeline Overview The Q4 Toxoplasmosis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development...
October 2020
30 pages
Tularaemia R&D Pipeline Analysis Report, Q4 2020
US$ 1,529.00
Tularaemia Pipeline Overview The Q4 Tularaemia pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for T...
October 2020
45 pages
Typhoid Fever R&D Pipeline Analysis Report, Q4 2020
US$ 1,529.00
Typhoid Fever Pipeline Overview The Q4 Typhoid Fever pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development...
October 2020
61 pages
Warts R&D Pipeline Analysis Report, Q4 2020
US$ 1,529.00
Warts Pipeline Overview The Q4 Warts pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Warts, prov...
October 2020
108 pages
Yellow Fever R&D Pipeline Analysis Report, Q4 2020
US$ 1,529.00
Yellow Fever Pipeline Overview The Q4 Yellow Fever pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development f...
October 2020
63 pages
Gummy Vitamins Market by Product Type (Multivitamins, Single Vitamins), Source (Animal, Plant), Packaging Type (Bottles & Jars, Pouches), Distribution Channel (Store-Based, Online), End User (Adult, Children), and Region - Global Forecast to 2025
US$ 2,970.00
According to MarketsandMarkets, the global gummy vitamins market size is estimated to be valued at USD 5.9 billion in 2020 and projected to reach USD 10.6 billion by 2025, recording a CAGR of 12.5%, i...
October 2020
194 pages
Pharmaceutical Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), Application (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat), Function (Stabilizing, Thickening, Gelling), Region - Global Forecast to 2025
US$ 2,970.00
The global pharmaceutical gelatin market is projected to reach USD 1.2 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 5.3% during the forecast period. Growth in this market is driven by th...
October 2020
190 pages
Schizophrenia - Market Insights, Epidemiology and Market Forecast - 2030
US$ 8,550.00
... Schizophrenia Pipeline Analysis Schizophrenia Market Size and Trends Schizophrenia Market Opportunities Impact of upcoming Therapies in Schizophrenia Schizophrenia Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
October 2020
391 pages
Acute lymphocytic leukemia (ALL) - Pipeline Insight, 2020
US$ 3,500.00
This report can be delivered to the clients within 72 - 96 Hours DelveInsight’s, “Acute Lymphocytic Leukemia – Pipeline Insight, 2020,” report provides comprehensive insights about 250+ companies an...
October 2020
180 pages
Polycythemia Vera - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 24 - 48 Hours DelveInsight’s, “Polycythemia vera – Pipeline Insight, 2020,” report provides comprehensive insights about 10+ companies and 10+ pipe...
October 2020
65 pages
Argininosuccinic aciduria - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 24 - 48 Hours DelveInsight’s, “Argininosuccinic aciduria (ASA) – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies...
October 2020
65 pages
Cytokine Release Syndrome – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 24 - 48 Hours DelveInsight’s, “Cytokine Release Syndrome – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies and 5...
October 2020
65 pages
Primary Sclerosing Cholangitis– Pipeline Insight, 2020
US$ 2,000.00
This report can be delivered to the clients within 48 - 72 Hours DelveInsight’s, “Primary Sclerosing Cholangitis– Pipeline Insight, 2020,” report provides comprehensive insights about 20+ companies...
October 2020
80 pages
Renal Tubular Acidosis (RTA) - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 24 - 48 Hours DelveInsight’s, “Renal tubular acidosis (RTA) – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies an...
October 2020
65 pages
